Your browser doesn't support javascript.
loading
A Syngeneic ErbB2 Mammary Cancer Model for Preclinical Immunotherapy Trials.
Pénzváltó, Zsófia; Chen, Jane Qian; Tepper, Clifford G; Davis, Ryan R; Silvestrini, Matthew T; Umeh-Garcia, Maxine; Sweeney, Colleen; Borowsky, Alexander D.
Afiliación
  • Pénzváltó Z; Center for Comparative Medicine, University of California at Davis, Davis, CA, USA.
  • Chen JQ; Center for Comparative Medicine, University of California at Davis, Davis, CA, USA.
  • Tepper CG; Department of Biochemistry and Molecular Medicine, School of Medicine, University of California at Davis, Sacramento, CA, USA.
  • Davis RR; Department of Pathology and Laboratory Medicine, School of Medicine, University of California at Davis, Sacramento, CA, USA.
  • Silvestrini MT; Department of Biomedical Engineering, University of California at Davis, Sacramento, CA, USA.
  • Umeh-Garcia M; Department of Biochemistry and Molecular Medicine, School of Medicine, University of California at Davis, Sacramento, CA, USA.
  • Sweeney C; Department of Biochemistry and Molecular Medicine, School of Medicine, University of California at Davis, Sacramento, CA, USA.
  • Borowsky AD; Center for Comparative Medicine, University of California at Davis, Davis, CA, USA. adborowsky@ucdavis.edu.
J Mammary Gland Biol Neoplasia ; 24(2): 149-162, 2019 06.
Article en En | MEDLINE | ID: mdl-30810966
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Antineoplásicos Inmunológicos / Neoplasias Mamarias Experimentales Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: J Mammary Gland Biol Neoplasia Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Antineoplásicos Inmunológicos / Neoplasias Mamarias Experimentales Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: J Mammary Gland Biol Neoplasia Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos